Literature DB >> 29735449

[Effect of bladder irrigation with amphotericin B for treatment of urinary tract fungal infection: a meta-analysis].

Yuan-Yuan Xiang1, Yu Lv, Ren Guo, Juan Xue.   

Abstract

OBJECTIVE: To assess the efficacy and safety of bladder irrigation with amphotericin B for treatment of fungal infection in the urinary tract.
METHODS: All the available randomized controlled trials (published before March, 2018) examining bladder irrigation with amphotericin B for treatment of urinary tract fungal infection were searched in the Cochrane Central Register of Controlled Trials (Issue 12, 2017), PubMed, EMBase, Web of Knowledge Database, CNKI, CBM, Wanfang DATA and VIP information. Data were extracted from the selected trials for meta-analysis using RevMan 5.3 software.
RESULTS: A total of 96 studies were retrieved from the databases, and 9 trials involving 853 patients were included in the analysis. Meta-analysis results showed that compared with oral administration of fluconazole, bladder irrigation with amphotericin B was more effective in the treatment of fungal infection in the urinary tract (OR=1.66, 95%CI: 1.2-2.3, P=0.002) and was associated with less adverse reactions.
CONCLUSION: Bladder irrigation with amphotericin B can improve the curative effect of fungal infection in the urinary tract, but due to the small sample size of the included studies, this conclusion needs to be further validated by high-quality studies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29735449      PMCID: PMC6765669     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  27 in total

1.  Guidelines for the use of antifungal agents in patients with invasive fungal infections in Taiwan--revised 2009.

Authors: 
Journal:  J Microbiol Immunol Infect       Date:  2010-06       Impact factor: 4.399

2.  Candidal cystitis. Management by continuous bladder irrigation with amphotericin B.

Authors:  G J Wise; S Wainstein; P Goldberg; P J Kozinn
Journal:  JAMA       Date:  1973-06-18       Impact factor: 56.272

3.  Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study.

Authors:  H S Leu; C T Huang
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

Review 4.  Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.

Authors:  Fernanda S Tonin; Laiza M Steimbach; Helena H Borba; Andreia C Sanches; Astrid Wiens; Roberto Pontarolo; Fernando Fernandez-Llimos
Journal:  J Pharm Pharmacol       Date:  2017-08-17       Impact factor: 3.765

5.  Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity.

Authors:  Sneha Gurudevan; Arul Prakash Francis; A Jayakrishnan
Journal:  Eur J Pharm Sci       Date:  2018-01-09       Impact factor: 4.384

Review 6.  Is it time to abandon the use of amphotericin B bladder irrigation?

Authors:  Richard H Drew; Rebekah R Arthur; John R Perfect
Journal:  Clin Infect Dis       Date:  2005-03-29       Impact factor: 9.079

7.  A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B.

Authors:  Délia Chaves Moreira Dos Santos; Marselle Leite Silvério de Souza; Eliane Morais Teixeira; Líndicy Leidicy Alves; José Mário Carneiro Vilela; Margareth Andrade; Maria das Graças Carvalho; Ana Paula Fernandes; Lucas Antônio Miranda Ferreira; Marta Marques Gontijo Aguiar
Journal:  J Drug Target       Date:  2017-10-18       Impact factor: 5.121

8.  Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria.

Authors:  P Fan-Havard; C O'Donovan; S M Smith; J Oh; M Bamberger; R H Eng
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

9.  Continuous versus intermittent bladder irrigation of amphotericin B for the treatment of candiduria.

Authors:  T Trinh; J Simonian; S Vigil; D Chin; M Bidair
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

10.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

View more
  1 in total

1.  Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria.

Authors:  Mark J Biagi; Nathan P Wiederhold; Connie Gibas; Brian L Wickes; Victoria Lozano; Susan C Bleasdale; Larry Danziger
Journal:  Open Forum Infect Dis       Date:  2019-06-01       Impact factor: 3.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.